(2R,3R)-2-(3,4-dimethoxyphenyl)-5,7-dimethoxychroman-3-yl 3,4,5-trimethoxybenzoate (6)
Yield: 96%; 
), 100.0 (C-10), 93.1 (C-8), 91.7 (C-6), 77.4 (C-2), 68. 
(2R, 3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-ol (7)
Yield: 98%; 
(2R,3R)-5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl) chroman-3-yl-3,4, 5-trimethoxybenzoate (8)
Yield: 98%; ), 152.8 To a solution of EGCG (458 mg, 1.0 mmol) in dry dimethylformamide (DMF, 10.0 mL) under nitrogen at -60 ºC, NaH (60% dispersion in mineral oil, 200 mg, 5.0 mmol) was added. After 2 h, BnBr (0.9 mL, 8.0 mmol) was added via a syringe. The mixture was stirred at -60 ºC for an additional 30 min and then at room temperature for 24 h.
The reaction was quenched by adding HCl (1 N, 2.0 mL) and water (15.0 mL). The aqueous layer was extracted with EtOAc (3 × 15 mL). The combined organic layers were washed with water and brine, then dried over Na 2 SO 4 and evaporated in vacuo. The residue was purified by CC (petroleum ether/ethyl acetate = 5:1) to afford the product 9 (250.0 mg, 25%). 
Synthesis of (2R,3R)-5,7-bis(benzyloxy)-2-(3,4,5-tris(benzyloxy)phenyl)chroman-3-ol (10)
2 To a solution of compound 9 (756.0 mg, 1.0 mmol) in MeOH (25.0 mL), NaOH (40 mg, 1.0 mmol) was added. The mixture was stirred at room temperature for 4 h, then it was concentrated, water was added, and the mixture was extracted with EtOAc (3 × 20.0 mL). The combined organic layers were dried over Na 2 SO 4 , and evaporated in vacuo. The residue was purified by CC (petroleum ether/ethyl acetate = 4:1) to afford the product 10 (680.4 mg, 90%). 
Synthesis of (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trimethoxybenzoate (11)
To a solution of compound 10 (1.0 mmol), 4-Dimethylaminopyridine (DMAP, 0.1 mmol), and
-dicyclohexylcarbodiimide (DCC, 0.3 mmol) in CH 2 Cl 2 was added with 3,4,5-trimethoxybenzoic acid (0.2 mmol).
The solution was stirred at room temperature for 12 h and the insoluble urea was filtered. The filtrate was concentrated under reduced pressure to provide a crude product, which was directly used for the next step. A solution of the above crude product (1.0 mmol) in MeOH (2.0 mL) was hydrogenated over 5% Pd/C (20 mg) for 4 h at room temperature. The mixture was filtered and the filtration residue was washed with MeOH (10 mL). The combined filtrates were evaporated in vacuo. The residue was purified by CC (petroleum ether/ethyl acetate = 1:1)
to afford the product 11 (260.0 mg, 52%). 
Synthesis of (2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate (12)
To a solution of compound 7 (1.0 mmol), DMAP (0.1 mmol), and DCC (0.3 mmol) in CH 2 Cl 2 , gallic acid (0.2 mmol) was added. The solution was stirred at room temperature for 12 h, and the insoluble urea was filtered. The filtrate was concentrated under reduced pressure. The residue was purified by CC (petroleum ether/ethyl acetate = 1:1)
to afford the product 12 (179.5 mg, 34%). 
Computational Studies
All computational studies were carried out using the Gaussian 09 software package. 3, 4 The structure of each prepared compound was fully optimized using the B3LYP/6-311++G (d, p) 5-7 computational level. A starting structure for the DFT calculations was prepared using the GaussView 5.0.8 software. 
Procedure for Antioxidant Activity Study
The antioxidant activity of the catechins and their derivatives was measured by DPPH assay. DPPH free radical scavenging capability was tested by the method described by Hung. 
Here, A sample is the absorbance of a sample solution, and A blank is the absorbance of the blank solution (containing all reagents except the test sample). The IC 50 value is the effective concentration that could scavenge 50% of the DPPH radicals.
